Peter JS CHIU,Mei-chi HSU,Ying-Chu SHIH,Edwin SC WU
申请号：
US15078342
公开号：
US20160287578A1
申请日:
2016.03.23
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to new medical uses of morphinans such as naltrexone, nalmefene and their related derivatives. The present invention relates to Toll-like receptor 4 (TLR4) antagonist compounds, and pharmaceutical formulations thereof, and use thereof for prevention and treatment of autoimmune liver diseases including but not limited to autoimmune hepatitis.
